Russia's Rosneft disappointed by EU Court’s decision on sanctions agains companyBusiness & Economy March 28, 13:10
US shuns constructive discussion of INF Treaty — LavrovRussian Politics & Diplomacy March 28, 13:01
Press review: EU may freeze Brexit talks and Kiev to step up pressure on Russian companiesPress Review March 28, 13:00
US missile defense in South Korea affects Russia’s sucurity — LavrovRussian Politics & Diplomacy March 28, 12:57
Russia-NATO Council to meet on March 30 in BrusselsRussian Politics & Diplomacy March 28, 12:54
Militants shelling Russian embassy in Damascus — General StaffWorld March 28, 12:38
Russian top diplomat stresses terrorists suffering defeat on Iraqi battlefieldRussian Politics & Diplomacy March 28, 12:20
Syrian army expands security zone around Palmyra — General StaffWorld March 28, 12:08
Russia’s General Staff blasts US-led coalition for destroying Syrian infrastructureMilitary & Defense March 28, 11:59
TOKYO, May 22, 2013 /PRNewswire/ -- Ranbaxy Laboratories Limited (hereafter, Ranbaxy), a subsidiary of Daiichi Sankyo Co., Ltd. (hereafter, Daiichi Sankyo), announced on May 22 the actions that Ranbaxy has taken in recent years to address past conduct under prior management.
Daiichi Sankyo continues to support Ranbaxy in its efforts to address and correct the conduct of the past which led to the investigations by the U.S. Department of Justice ("DOJ") and the U.S. Food and Drug Administration ("USFDA"). These efforts include significant changes to Ranbaxy's management, culture, operations and compliance.
Daiichi Sankyo believes that certain former shareholders of Ranbaxy concealed and misrepresented critical information concerning the U.S. DOJ and FDA investigations. Daiichi Sankyo is currently pursuing its available legal remedies and cannot comment further on the subject at this time.
About Daiichi Sankyo Co., Ltd.
Listed: Code No.: 4568, First Section of Tokyo, Osaka and Nagoya Stock Exchanges
President and CEO: Joji Nakayama
Noriaki Ishida, Corporate Officer & Vice President Corporate Communications Department Daiichi Sankyo Co., Ltd.